WellStack, a healthcare data and AI company, has announced the acquisition of DeLorean AI, a healthcare-focused artificial intelligence company specializing in predictive analytics, risk stratification, and decision support.

The acquisition expands WellStack’s capabilities beyond healthcare data aggregation and analytics, with the combined platform designed to help organizations identify emerging risks, predict potential outcomes, and determine recommended actions.

Combining Healthcare Data With Predictive AI

WellStack’s existing platform brings together healthcare data, analytics, and AI-enabled workflows. DeLorean AI adds predictive intelligence that continuously evaluates clinical, claims, and operational information to identify patients, processes, and financial areas that may require attention.

The combined capabilities are intended to help healthcare organizations move from understanding historical events to anticipating what may happen next and identifying appropriate interventions.

From Data to Action

The companies describe the combined offering as an end-to-end decision intelligence platform. It is designed to connect several stages of the healthcare decision process:

• Data aggregation: Bringing together healthcare and operational information.

• Risk identification: Detecting emerging clinical, operational, and financial risks.

• Prediction: Forecasting potential adverse events and other outcomes.

• Recommended action: Providing evidence-based next steps for clinical and operational teams.

• Measurement: Tracking the impact of interventions and decisions.

DeLorean AI’s technology is intended to help organizations identify risks earlier and intervene before they result in avoidable costs or adverse outcomes.

Building a Healthcare Intelligence Operating System

WellStack says the acquisition supports its broader goal of becoming a “precision intelligence operating system” for healthcare by combining data, AI, and human expertise in a single environment.

The integration is also intended to reduce the gap between healthcare data platforms and actionable intelligence. Rather than requiring organizations to interpret large volumes of information independently, the combined system aims to surface relevant risks and connect them with recommended actions.

Supporting Clinical, Operational and Financial Outcomes

According to the companies, client case studies have shown improvements in areas including patient adherence, avoidable utilization, and revenue optimization.

The acquisition is expected to further integrate DeLorean AI’s predictive capabilities with WellStack’s healthcare data platform, analytics modules, and AI-enabled user experience.